Tech Company Financing Transactions
GrayBug Vision Funding Round
GrayBug Vision closed a $750 thousand venture capital round on 12/21/2015. Investors included private investors.
Transaction Overview
Company Name
Announced On
12/21/2015
Transaction Type
Debt
Amount
$750,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 1 investor participated in the offering. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
275 Shoreline Dr. 450
Redwood City, CA 94065
USA
Redwood City, CA 94065
USA
Phone
Website
Email Address
Overview
Graybug Vision (Nasdaq: GRAY) is developing products to reduce the frequency of dosing for ocular therapies using its injectable controlled release technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Frédéric Guerard
Chief Medical Officer
Charles Semba
Chief Operating Officer
Daniel Salain
VP - Operations
Valerie Smith
VP - Product Management
Rajendra Mohabir
VP - R & D
Ming Yang
VP - Regulatory Affairs
Karl Trass
Browse more venture capital transactions:
Prev: 12/21/2015: Flux Factory venture capital transaction
Next: 12/21/2015: Consensus venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs